BioMedTracker is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

Informa
Menu

Impact Events

More
Date Lead Company Event Type Approval Change Approval Likelihood
1/17/22 Sensorion (ALSEN) Arazasetron for Hearing Loss - General Subscribers Only Subscribers Only Subscribers Only
1/13/22 AstraZeneca (AZN) AZD2816 for COVID-19 Prevention Subscribers Only Subscribers Only Subscribers Only
1/12/22 Pfizer (PFE) Prevnar 20 for Pneumococcal (Streptococcus pneumoniae) Vaccines (Antibacterial) Subscribers Only Subscribers Only Subscribers Only
1/10/22 Allogene Therapeutics (ALLO) ALLO-316 for Renal Cell Cancer (RCC) Subscribers Only Subscribers Only Subscribers Only
1/10/22 Allogene Therapeutics (ALLO) ALLO-501A for Non-Hodgkin's Lymphoma (NHL) Subscribers Only Subscribers Only Subscribers Only

Upcoming Catalysts

More
Expected Date Range Lead Company Drug Expected Catalyst
01/17/22 Subscribers Only Subscribers Only Regulatory - Supplemental Approval (Europe)
01/17/22 Subscribers Only Subscribers Only Regulatory - Approval Decision (Europe)
01/17/22 Subscribers Only Subscribers Only Regulatory - Supplemental Approval (Europe)
01/17/22 Subscribers Only Subscribers Only Regulatory - Supplemental Approval (Europe)
01/17/22 Subscribers Only Subscribers Only Regulatory - Supplemental Approval (Europe)
Back to the top Back to the top